Pheochromocytoma-paraganglioma is a rare condition in which certain nerve-related cells form tumors that make too much adrenaline-like hormone or grow in other parts of the body. Early symptoms of pheochromocytoma-paraganglioma can include sudden headaches, sweating, a racing heartbeat, high blood pressure, and spells of anxiety or shakiness. It can affect adults and children, and some cases are linked to an inherited gene change. Not everyone will have the same experience. Treatment usually involves surgery, and some people also need medicines, radiation, or other tumor-directed care, while the outlook depends on where the tumor is, whether it has spread, and how well blood pressure is controlled.
How many people live with Pheochromocytoma-paraganglioma?
Because rare tumors like pheochromocytoma-paraganglioma are diagnosed and counted differently across studies, estimates are usually given as a range: widely cited rare-disease sources suggest about 1 in 2,500 to 1 in 6,500 people may be living with it, which works out to roughly 1.3 to 3.3 million people worldwide (National Organization for Rare Disorders, 2023). Using the same range, about 52,000 to 135,000 people in the United States may be living with it (National Organization for Rare Disorders, 2023).
Overview
Pheochromocytoma-paragangliomaSymptoms
Pheochromocytoma-paraganglioma often causes spells of high blood pressure, pounding headaches, sweating, and a fast or racing heartbeat. Early symptoms of pheochromocytoma-paraganglioma can also include shakiness, anxiety, chest or belly pain, and weight loss.
Outlook and prognosis
With pheochromocytoma-paraganglioma, outlook often depends on where the tumor is, whether it has spread, and whether surgery can remove it fully. Many people do well after treatment, but long-term follow-up is important because these tumors can come back.
Causes and risk factors
Pheochromocytoma-paraganglioma often arises from inherited gene changes, so family history is a major risk factor. Some cases start from new genetic changes or happen without a clear cause. Rarely, long-term low oxygen may raise risk.
Genetic influences
Genetics are very important in pheochromocytoma-paraganglioma, because many cases are linked to inherited gene changes. Genetic testing often helps explain why it happened and can guide screening for family members.
Diagnosis
Pheochromocytoma-paraganglioma is diagnosed with blood or urine tests that look for extra stress hormones. If results suggest Pheochromocytoma-paraganglioma, imaging such as CT, MRI, or nuclear scans helps find the tumor. Genetic testing may also be recommended.
Treatment and drugs
Treatment for pheochromocytoma-paraganglioma usually starts with medicines to control very high blood pressure and steady the heart before surgery. Surgery is often the main treatment, and some people also need targeted radiation or drug therapy if the tumor has spread or returns.
Symptoms
Life with pheochromocytoma-paraganglioma can involve sudden spells of feeling unwell, like a pounding heartbeat, drenching sweat, or a severe headache that seems to come out of nowhere. These episodes may last minutes to hours, or symptoms may be more constant. Early symptoms of pheochromocytoma-paraganglioma can be mistaken for panic attacks, migraines, or hard-to-control high blood pressure. Symptoms vary from person to person and can change over time.
Blood pressure may stay high all the time or spike suddenly in attacks. Many people with pheochromocytoma-paraganglioma feel flushed, unwell, or as if their body is under sudden strain during these surges.
Headaches are one of the most common symptoms and are often strong, throbbing, and abrupt. Many living with pheochromocytoma-paraganglioma notice that the pain comes with a spell rather than building slowly like a typical tension headache.
Sweating can be heavy and sudden, even in a cool room or without exercise. Clothes may feel damp within minutes, and some people also feel hot or clammy.
The heart may pound, race, or seem to skip beats during a hormone surge. Day to day, it can feel like your chest is fluttering after only mild activity or while sitting still.
How people usually first notice Pheochromocytoma-paraganglioma?
Many people first notice pheochromocytoma-paraganglioma when sudden spells start happening: pounding headaches, a racing or pounding heartbeat, heavy sweating, shakiness, anxiety, or blood pressure that rises in bursts and can make you feel panicky or unwell. How pheochromocytoma-paraganglioma is first noticed can vary, though, because some tumors in the neck or head cause a painless lump, hoarseness, ringing in the ears, or hearing changes instead of the classic hormone-related attacks. In other people, the first signs of pheochromocytoma-paraganglioma show up during a scan for something else or through genetic testing and screening after a family member is diagnosed.
Types of Pheochromocytoma-paraganglioma
Pheochromocytoma-paraganglioma includes a few recognized tumor types, mainly based on where the growth starts in the body. That location often shapes how it behaves and which symptoms are more likely. Symptoms don’t always look the same for everyone. When people ask about the types of pheochromocytoma-paraganglioma, doctors usually mean adrenal pheochromocytoma, sympathetic paraganglioma, and head and neck paraganglioma.
Pheochromocytoma
This type starts in the adrenal gland, which sits above the kidneys. It often causes bursts of stress hormones, so many living with pheochromocytoma-paraganglioma notice sudden headaches, pounding heartbeat, sweating, shakiness, or spells of high blood pressure. Some also feel anxious or panicky during these episodes, even when nothing stressful is happening.
Sympathetic paraganglioma
This type grows outside the adrenal gland, usually in the chest, abdomen, or pelvis along nerves that help control blood pressure and the stress response. It can cause symptoms much like pheochromocytoma, including headaches, sweating, palpitations, and high blood pressure, but some may also have pain or pressure from the tumor itself depending on where it is. The balance of symptoms can shift over time.
Head and neck paraganglioma
This type usually forms near blood vessels and nerves in the head or neck. Unlike the hormone-secreting forms, it often does not cause the classic adrenaline-like spells and may instead show up as a neck lump, ringing in the ear, hearing changes, hoarseness, trouble swallowing, or pressure in the face or throat. For many, this can mean symptoms are noticed during daily activities like talking, eating, or turning the head.
Can I slow down the onset of symptoms?
There is no good evidence that lifestyle changes can meaningfully delay the start of symptoms in pheochromocytoma-paraganglioma, a group of rare tumors that can release stress hormones, because these tumors are usually driven by gene changes rather than everyday habits. Healthy basics like not smoking, keeping blood pressure well managed, and avoiding stimulant drugs may help lower strain on the body or reduce symptom flare-ups, but they have not been shown to prevent the condition or reliably delay when symptoms begin. If you have a known inherited risk or a strong family history, regular follow-up with blood or urine tests and scans is the best-established medical step to find problems early, and while that cannot guarantee prevention, it can still help you get care sooner.
What genetics can tell you about symptoms
Genetics can sometimes help explain why pheochromocytoma-paraganglioma shows up differently from one person to another, including which tumors are more likely to form, the age they begin, and how likely they are to make extra stress hormones that cause spells of headaches, pounding heartbeat, sweating, or high blood pressure. Certain inherited gene changes are also linked with a higher chance of multiple tumors, tumors outside the adrenal gland, or a greater risk that the condition may act more aggressively, although symptoms can still vary a lot even within the same family. In short, genetic testing cannot predict every symptom, but it can give useful clues about what doctors may watch for and how closely someone should be followed over time.
Causes and risk factors
In many people, pheochromocytoma-paraganglioma develops because of a gene change that is inherited or happens for the first time. Family history and certain inherited conditions raise the risk, and these tumors often appear at a younger age in people with a hereditary cause. Having a gene change doesn't mean you'll definitely develop the condition. Long-term low oxygen, such as living at high altitude or having some heart or lung diseases, may raise the risk of certain paragangliomas. No clear lifestyle habit is known to directly cause pheochromocytoma-paraganglioma, and genetic testing for pheochromocytoma-paraganglioma can help clarify risk if these tumors run in your family.
What are the most common causes or risk factors?
The main known cause of pheochromocytoma-paraganglioma is a change in genes that affects how certain hormone-making or nerve-related cells grow, and these changes are often inherited. Because of that, the biggest risk factors are a close family history and certain rare inherited conditions that make tumors more likely; for some paragangliomas, long-term low oxygen, such as from living at high altitude or some heart or lung problems, may also raise risk.
Environmental and biological risk factors
Non-genetic risk factors for pheochromocytoma-paraganglioma are less clear than they are for many other tumors. Most people who develop it do not have one obvious outside cause. Doctors often group risks into internal (biological) and external (environmental).
These tumors can develop at almost any age, but many are found in adults. Risk tends to rise across adulthood, and many cases are diagnosed between ages 30 and 50.
Long-term low oxygen levels may raise the chance of some paragangliomas, especially in the head and neck. This has been seen in people living at high altitude and in some conditions that keep blood oxygen low for years.
Past high-dose radiation, especially to the head and neck, may increase paraganglioma risk later in life. This is not a common cause, but doctors may ask about prior radiation treatment or major exposure.
Head and neck paragangliomas are diagnosed somewhat more often in women than in men. This difference is modest, so it cannot predict who will develop pheochromocytoma-paraganglioma.
Genetic risk factors
For many families, one of the first questions after a pheochromocytoma-paraganglioma diagnosis is whether it runs in the family. Pheochromocytoma-paraganglioma is more often inherited than many other tumors, and about 30% to 40% of cases are linked to a gene change passed down through families. Some risk factors are inherited through our genes. Understanding the genetic causes of pheochromocytoma-paraganglioma can help guide genetic testing, even though carrying a gene change does not always mean a tumor will develop.
Family history: Having a parent, sibling, or child with pheochromocytoma-paraganglioma or with a related inherited syndrome raises the chance of a shared gene change. Even without a clear family history, an inherited cause is still possible because some relatives may never develop symptoms or were never diagnosed.
SDHB change: Changes in SDHB are a well-known inherited cause of pheochromocytoma-paraganglioma. They often raise the risk of paragangliomas outside the adrenal glands, and these tumors have a higher chance of spreading than some other genetic types.
Other SDH genes: Changes in SDHD, SDHC, SDHA, and SDHAF2 can also lead to these tumors. Many living with these gene changes develop paragangliomas in the head and neck area, and with SDHD or SDHAF2 the risk is often stronger when the change is inherited from the father.
VHL syndrome: Von Hippel-Lindau syndrome can increase the risk of pheochromocytoma, especially in younger people. Families with VHL may also have kidney tumors, pancreatic cysts or tumors, or growths in the eyes, brain, or spinal cord.
RET and MEN2: A change in RET causes multiple endocrine neoplasia type 2, often shortened to MEN2. People with MEN2 can develop pheochromocytoma along with medullary thyroid cancer and, in some families, overactive parathyroid glands.
NF1: Neurofibromatosis type 1 is another inherited condition linked to pheochromocytoma. Many people with NF1 also have café-au-lait spots and soft skin growths called neurofibromas, so those features can be a clue that the tumor is part of a broader genetic condition.
TMEM127 and MAX: These less common inherited gene changes can also raise the risk of pheochromocytoma-paraganglioma. In some families, they are linked to tumors in both adrenal glands or to more than one tumor over time.
Rarer genes: A smaller number of people have inherited changes in rarer genes that affect how cells use oxygen and energy. This is one reason genetic testing for pheochromocytoma-paraganglioma often looks at a panel of genes rather than only one.
Lifestyle risk factors
Lifestyle habits do not cause pheochromocytoma-paraganglioma, but they can strongly influence symptom flares, blood pressure swings, and treatment safety. Because these tumors can release excess catecholamines, some everyday behaviors can provoke palpitations, headaches, sweating, or dangerous hypertension. Understanding how lifestyle affects pheochromocytoma-paraganglioma can help people reduce triggers and support recovery before and after treatment.
Caffeine, nicotine, energy drinks, and recreational stimulants can intensify catecholamine-related symptoms such as racing heart, tremor, and blood pressure spikes. Limiting or avoiding them may reduce sudden symptom surges and lower the chance of a hypertensive crisis.
Alcohol can trigger flushing, palpitations, headache, and blood pressure instability in some people with pheochromocytoma-paraganglioma. Reducing intake may help make symptoms more predictable and improve safety while the tumor is being evaluated or treated.
Intense exercise, heavy lifting, and straining can provoke catecholamine release and bring on pounding heartbeat, chest discomfort, or severe hypertension. Gentle, clinician-guided activity is often safer than sudden maximal effort until treatment is complete.
Emotional stress, panic, and poor stress control can worsen adrenergic symptoms and make episodes feel more frequent or severe. Stress-reduction practices may help blunt symptom triggers, although they do not treat the tumor itself.
Risk prevention
For pheochromocytoma-paraganglioma, true prevention is often limited because many cases are linked to inherited gene changes rather than lifestyle alone. Some prevention is universal, others are tailored to people with specific risks. In practice, this usually means finding inherited risk early, watching closely for new tumors, and lowering the chance of dangerous hormone-related complications.
If pheochromocytoma-paraganglioma runs in your family or was diagnosed at a young age, genetic counseling and testing can help clarify risk. This can identify who in the family may benefit from earlier screening and closer follow-up.
Close relatives of someone with hereditary pheochromocytoma-paraganglioma may need regular checkups, blood or urine testing, and imaging over time. Screening cannot stop a tumor from forming, but it can catch it earlier when treatment is often safer and simpler.
People living with pheochromocytoma-paraganglioma, or those at high inherited risk, often need planned follow-up with blood pressure checks, lab tests, and scans. Knowing the early symptoms of pheochromocytoma-paraganglioma, such as pounding headaches, sweating, racing heartbeat, or sudden high blood pressure, can also help prompt faster care.
Some medicines can trigger hormone surges or make symptoms worse in people with pheochromocytoma-paraganglioma. Reviewing prescription drugs, over-the-counter products, and supplements with your care team can help avoid preventable spikes in blood pressure.
Can you prevent Pheochromocytoma-paraganglioma?
Pheochromocytoma-paraganglioma usually cannot be prevented, because many cases happen due to inherited gene changes or causes that are not under your control. There are no proven lifestyle steps that clearly stop these tumors from forming. If this condition runs in your family, genetic counseling and regular checkups may help find it early, but that is not the same as preventing it.
Transmission
Pheochromocytoma-paraganglioma is not contagious, so it cannot be spread from one person to another through touching, kissing, coughing, sex, or sharing food. For many living with pheochromocytoma-paraganglioma, the more relevant issue is the genetic transmission of pheochromocytoma-paraganglioma, not infectivity.
Some cases are linked to a gene change passed from a parent to a child, and in many families one changed copy is enough to increase risk. Other cases are not inherited and happen for the first time in the affected person, so genetic counseling and, when appropriate, family testing can help clarify risk for relatives.
When to test your genes
Genetic testing is usually recommended for anyone diagnosed with pheochromocytoma or paraganglioma, because inherited risk is common and results can guide screening, treatment, and family testing. It is especially important if tumors appear at a young age, are multiple or bilateral, come back, or there is a family history.
Diagnosis
Pheochromocytoma-paraganglioma is usually diagnosed after symptoms or an unexpected mass raise concern. Many living with this condition come to testing because of spells of pounding headaches, heavy sweating, a racing heartbeat, or high blood pressure that is hard to explain. Doctors usually begin with lab tests that look for extra stress hormones made by the tumor, and the diagnosis of pheochromocytoma-paraganglioma is then confirmed with imaging and, in many cases, genetic testing.
A clinician will ask about episodes of headache, sweating, palpitations, shaking, anxiety, or blood pressure spikes. Timing matters, because symptoms often come in sudden spells rather than staying constant.
Blood pressure is checked carefully, sometimes more than once and in different positions. This helps show whether pressure is consistently high or rises in bursts, which can happen with pheochromocytoma-paraganglioma.
Blood tests or a 24-hour urine collection measure breakdown products of adrenaline-like hormones. High levels strongly suggest the tumor is active, although medicines, stress, and some foods may affect results.
CT or MRI scans are used to find the tumor and show its size and location. These scans can look at the adrenal glands as well as other areas in the chest, abdomen, pelvis, head, and neck.
How is Pheochromocytoma-paraganglioma diagnosed?
Pheochromocytoma-paraganglioma is usually diagnosed with blood tests or a 24-hour urine test that look for unusually high levels of stress hormones and the substances they break down into. If those results point to one of these tumors, imaging scans such as a CT scan, MRI, or sometimes a special whole-body scan are used to find it and check whether there is more than one. Because these tumors can sometimes run in families, many people are also offered genetic testing to see if an inherited gene change is involved.
Stages of Pheochromocytoma-paraganglioma
Pheochromocytoma-paraganglioma does not have defined progression stages. These tumors are usually identified by where they arise, whether they make extra stress hormones, and whether they stay localized or spread, rather than by a steady step-by-step decline over time. Doctors usually start with a conversation about symptoms such as pounding headaches, sweating, a racing heartbeat, or spells of very high blood pressure, then use blood or urine tests to look for hormone changes. Imaging scans such as CT or MRI help show the tumor’s location, and in some cases genetic testing is part of how pheochromocytoma-paraganglioma is diagnosed and monitored.
Outlook and prognosis
Outlook for people with pheochromocytoma-paraganglioma is often good when the tumor is found early and completely removed, because many tumors are localized and curable with surgery. Prognosis depends mainly on whether the tumor has spread, whether it can be fully resected, where it arises, and whether there is an inherited mutation such as SDHB, which is associated with a higher risk of metastatic disease. Even after successful treatment, lifelong follow-up is usually recommended because recurrence or new tumors can occur years later, especially in hereditary cases. Metastatic pheochromocytoma-paraganglioma can behave unpredictably, with some patients living for many years with treatment while others have more aggressive progression. Death is uncommon in well-managed localized disease, but mortality rises when there is uncontrolled hormone excess causing cardiovascular complications or when the cancer is widely metastatic. Early diagnosis, expert blood pressure control, genetic evaluation, and long-term surveillance all improve the overall outlook.
Long-term effects
Pheochromocytoma-paraganglioma can have lasting effects even after treatment, mainly because these tumors may keep making stress hormones, come back later, or in some cases spread to other parts of the body. For many, symptoms improve once the tumor is removed, but blood pressure and heart-related problems do not always settle right away. The long-term picture is often shaped by where the tumor started, whether it was fully removed, and whether there is an inherited gene change.
Long-standing hormone surges from pheochromocytoma-paraganglioma can leave some people with ongoing high blood pressure, even after treatment. Over time, this can raise the risk of stroke, heart attack, kidney damage, and other blood vessel problems.
Repeated bursts of stress hormones can weaken or irritate the heart muscle. Some people develop abnormal heart rhythms, chest pain, or a form of heart failure, especially if the tumor was active for a long time before diagnosis.
Pheochromocytoma-paraganglioma can return months or years after apparently successful treatment. Because early symptoms of recurrent pheochromocytoma-paraganglioma can look like the first episode, doctors usually recommend long-term follow-up.
In some people, pheochromocytoma-paraganglioma becomes metastatic, meaning it spreads to places such as bone, liver, lung, or lymph nodes. This can lead to ongoing pain, fatigue, hormone-related symptoms, and a more complicated long-term outlook.
How is it to live with Pheochromocytoma-paraganglioma?
Living with pheochromocytoma-paraganglioma can feel unpredictable, because these tumors may release bursts of stress hormones that trigger pounding headaches, racing heartbeat, sweating, shaking, and sudden spikes in blood pressure, sometimes making work, exercise, travel, or even routine errands hard to plan. For many people, daily life also includes regular scans, blood or urine testing, careful blood pressure monitoring, and sometimes surgery or long-term follow-up, especially because some tumors can come back or occur as part of an inherited condition. This often affects the people around you too: family members may worry during symptom flares, help during treatment and appointments, and in some cases may be offered genetic testing themselves, but with expert care and a clear follow-up plan, many living with pheochromocytoma-paraganglioma are able to regain a strong sense of control.
Treatment and drugs
Treatment for pheochromocytoma-paraganglioma usually focuses on safely removing the tumor, but care often starts before surgery because these tumors can release stress hormones that sharply raise blood pressure and strain the heart. Before an operation, people with pheochromocytoma-paraganglioma are often given medicines to control blood pressure and slow a fast heartbeat, and they may be asked to drink more fluids and increase salt intake so the body is better prepared for surgery. If the tumor cannot be fully removed, has spread, or comes back, treatment may also include targeted radiation, medicines that deliver radiation directly to tumor cells, chemotherapy, or other drug treatments chosen based on the tumor’s features and sometimes its gene changes. Not every treatment works the same way for every person, so follow-up care is important and usually includes repeat scans, blood or urine testing, and ongoing blood pressure checks. For many people, treatment begins with small daily steps, such as taking medicines exactly as prescribed and keeping close contact with a specialist team experienced in pheochromocytoma-paraganglioma.
Can you cure Pheochromocytoma-paraganglioma?
For many people with pheochromocytoma-paraganglioma, surgery can cure it if the tumor is found early and can be fully removed before it has spread. If it has spread, comes back, or cannot be safely taken out, there usually is not a full cure, but treatment can control hormone-related symptoms, lower blood pressure, and slow or shrink the tumors.
Non-drug treatment
Living with pheochromocytoma-paraganglioma often means dealing with sudden spikes in blood pressure, pounding headaches, sweating, or a racing heartbeat that can disrupt ordinary moments, like climbing stairs or feeling stressed at work. Treatment usually centers on procedures rather than lifestyle changes alone, because the main goal is to remove or control the tumor safely and lower the risk of dangerous hormone surges. For many, treatment begins not at the pharmacy, but with surgery, imaging-guided procedures, radiation, and long-term follow-up at a center familiar with these rare tumors. Because some tumors run in families, care often includes genetic counseling and screening plans for relatives.
Surgery is the main non-drug treatment for many people with pheochromocytoma-paraganglioma, especially when the tumor can be removed completely. Taking out the tumor can relieve symptoms and reduce the risk of severe blood pressure swings, although medicines are usually used around the time of surgery to make the operation safer.
In some cases, surgeons may remove only part of an adrenal gland to preserve hormone function, especially if both sides are affected or an inherited condition raises the chance of future tumors. This approach is not right for everyone, but it can help some people avoid lifelong steroid replacement.
Focused radiation may be used when a tumor cannot be removed safely, has spread, or is causing pain or pressure on nearby structures. Some non-drug options are delivered by specialists, and radiation can help control tumor growth and ease symptoms rather than cure the disease.
Heat- or cold-based treatments, guided by scans, can sometimes target selected tumors in the body or liver. These procedures may help control symptoms or reduce tumor burden in people with metastatic pheochromocytoma-paraganglioma when surgery is not the best option.
Your genes may have an impact on how drugs work for you
For many living with pheochromocytoma-paraganglioma, the medicines used first to control dangerous blood pressure swings and other hormone-related symptoms are usually chosen based on symptoms and blood pressure, not on inherited gene changes. The genetic changes linked to this condition can matter more when the tumor is advanced or has spread, because they may help doctors decide which longer-term treatments are more likely to work, including certain targeted medicines or radioactive drug treatments. In everyday care, this means genetic testing often helps guide the treatment plan, even though it does not usually change the basic symptom-control medicines used at the start.
Pharmacological treatments
Treatment for pheochromocytoma-paraganglioma often starts with medicines that control the surge of stress hormones these tumors can release, especially before surgery. The main goals are to lower blood pressure, steady the heart rate, and reduce symptoms such as pounding headaches, sweating, and palpitations. For advanced or inoperable pheochromocytoma-paraganglioma, some people also need drug-based tumor treatments that aim to slow growth or shrink the cancer. Not everyone responds to the same medication in the same way.
Phenoxybenzamine is a commonly used alpha blocker that helps relax blood vessels before surgery or when hormone-related symptoms are hard to control. This can lower blood pressure and reduce spells of headache, sweating, and shaking.
Doxazosin, prazosin, and terazosin are also alpha blockers used for pheochromocytoma-paraganglioma, often as alternatives to phenoxybenzamine. They help control high blood pressure and may be easier for some people to tolerate.
Propranolol, atenolol, or metoprolol may be added after an alpha blocker is already in place if the heart is racing or pounding. Starting a beta blocker first can be unsafe because it may sharply worsen blood pressure.
Nicardipine or amlodipine can help lower blood pressure and may be used with or instead of other medicines in some cases. They are sometimes useful when symptoms are milder or when alpha blockers cause troublesome side effects.
Genetic influences
For many living with pheochromocytoma-paraganglioma, one of the first questions is whether it could be inherited. A surprisingly large share of pheochromocytoma-paraganglioma cases are linked to inherited gene changes, so family history is one of the strongest clues to a genetic influence. These changes often involve the SDH family of genes, and less commonly genes such as VHL, RET, NF1, TMEM127, or MAX, which help control how certain nerve-related cells grow and respond to oxygen and stress signals. Because of this, people with pheochromocytoma-paraganglioma are often offered genetic testing even if no relatives are known to have had the condition. The results can help explain why tumors appeared at a younger age, in both adrenal glands, or in more than one place, and they can show whether close relatives may also be at risk. Genetic testing for pheochromocytoma-paraganglioma can also help guide follow-up care and show which family members may benefit from counseling or screening.
Is Pheochromocytoma-paraganglioma genetic?
Genetics are very important in pheochromocytoma-paraganglioma, because many cases are linked to inherited gene changes. Genetic testing often helps explain why it happened and can guide screening for family members.
Having a genetic risk is not necessarily a diagnosis
Gene variants are a normal part of human biology and are common across the general population. Most do not directly affect health and are simply part of natural human diversity. For many genes, having a variant tied to a condition points to a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When pheochromocytoma-paraganglioma causes blood pressure spikes, sweating, or pounding headaches, treatment is not only about calming those symptoms or removing the tumor; the gene change behind it can also shape what comes next. Not every difference in response is genetic, but inherited changes such as SDHB, RET, VHL, or NF1 can affect how likely the tumor is to involve both adrenal glands, come back, or spread, which can influence surgery, follow-up, and family screening. In advanced pheochromocytoma-paraganglioma, doctors may use the genetic result together with tumor scans to decide whether a specialized radioactive treatment, chemotherapy, or another targeted approach is more likely to help. This is one reason genetic testing for pheochromocytoma-paraganglioma is often part of treatment planning, not just diagnosis. Genetics can also guide how closely many living with pheochromocytoma-paraganglioma are monitored after treatment, since some gene changes carry a higher long-term risk than others. Even so, treatment decisions still depend on the tumor’s location, hormone production, age, and overall health, not genes alone.
Interactions with other conditions
Pheochromocytoma-paraganglioma can affect more than just blood pressure, and for many living with it, the hardest part is that it may overlap with other health problems at the same time. Doctors call it a comorbidity when two conditions occur together. These tumors are especially important to look for in people with certain inherited conditions, including multiple endocrine neoplasia type 2, von Hippel-Lindau disease, and neurofibromatosis type 1, because the chance of developing pheochromocytoma-paraganglioma is higher in those settings. The hormone surges from pheochromocytoma-paraganglioma can also worsen heart disease, trigger dangerous spikes in blood pressure, and raise the risk of stroke, irregular heartbeat, or stress-related heart weakness. Some may also develop high blood sugar or diabetes-like changes, so the early symptoms of pheochromocytoma-paraganglioma can sometimes be mistaken for more common conditions such as panic attacks, migraine, or uncontrolled hypertension. Because of this, care often involves checking for related diseases and making sure any heart, endocrine, or genetic issues are treated together rather than one by one.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Pheochromocytoma-paraganglioma?
Symptoms of pheochromocytoma-paraganglioma can also happen with panic attacks or anxiety, an overactive thyroid, uncontrolled high blood pressure, low blood sugar, heart rhythm problems, and sometimes menopause-related hot flashes. Some medicines and stimulants, such as decongestants, asthma inhalers, caffeine, and illegal stimulant drugs, can also cause episodes of pounding heartbeat, sweating, shaking, and headache that seem very similar. Because these problems can overlap so much, doctors usually need blood or urine tests and scans to tell them apart.
History
People living with pheochromocytoma-paraganglioma have often faced a long path to diagnosis, partly because the condition can look like more common problems such as anxiety, migraines, panic attacks, or hard-to-control high blood pressure. Someone might have sudden pounding headaches, sweating, and a racing heartbeat that come and go, then feel fairly normal between episodes, which made these tumors difficult to recognize in earlier times.
Throughout history, people have described attacks that sound very similar to what we now know can happen with pheochromocytoma-paraganglioma, but doctors could not clearly explain them until modern pathology and imaging developed. In the late 1800s and early 1900s, physicians began linking these dramatic spells to rare tumors in the adrenal glands and related nerve tissue. Over time, descriptions became more precise, and doctors learned that closely related tumors could arise in different parts of the body, which is why the name now includes both pheochromocytoma and paraganglioma.
As medical science evolved, better blood and urine testing helped confirm that these tumors can release bursts of stress hormones, explaining symptoms like shaking, palpitations, sweating, and severe spikes in blood pressure. Imaging scans then made it easier to find the tumors before surgery, which greatly improved care. In recent decades, researchers also recognized that some cases run in families and later identified a genetic cause in a substantial number of people, changing how relatives may be assessed and followed.
The history of pheochromocytoma-paraganglioma is also a story of clearer diagnosis and safer treatment. Earlier surgery was much riskier because the tumor could trigger sudden blood pressure changes during an operation. Today, careful preparation with medicines before surgery has made treatment much safer for many people. Knowing this history helps explain why early symptoms of pheochromocytoma-paraganglioma can still be missed at first, but it also shows how much diagnosis and care have improved.